MORGAN STANLEY - CALLIDITAS THERAPEUTICS AB ownership

CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 18 filers reported holding CALLIDITAS THERAPEUTICS AB in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CALLIDITAS THERAPEUTICS AB
ValueSharesWeighting
Q3 2023$42,509
+1.0%
2,328
-12.3%
0.00%
Q2 2023$42,069
+26.5%
2,656
+91.5%
0.00%
Q1 2023$33,246
+36.0%
1,387
-3.5%
0.00%
Q4 2022$24,446
+35.8%
1,438
+26.9%
0.00%
Q3 2022$18,000
-76.3%
1,133
-73.6%
0.00%
Q2 2022$76,000
+442.9%
4,295
+489.2%
0.00%
Q1 2022$14,000
-79.7%
729
-73.5%
0.00%
Q4 2021$69,000
+60.5%
2,755
+37.4%
0.00%
Q3 2021$43,000
+43.3%
2,005
+97.9%
0.00%
Q2 2021$30,000
+57.9%
1,013
+45.5%
0.00%
Q1 2021$19,000
+850.0%
696
+908.7%
0.00%
Q2 2020$2,000690.00%
Other shareholders
CALLIDITAS THERAPEUTICS AB shareholders Q1 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 200,000$6,724,0002.33%
BVF INC/IL 750,000$25,493,0001.00%
Logos Global Management LP 300,000$10,086,0000.86%
Vivo Capital, LLC 311,030$10,457,0000.47%
HHLR ADVISORS, LTD. 1,047,687$35,611,0000.28%
Pentwater Capital Management LP 50,000$1,681,0000.02%
Point72 Asset Management, L.P. 102,748$3,454,0000.02%
DEUTSCHE BANK AG\ 70,236$2,361,0000.00%
MILLENNIUM MANAGEMENT LLC 20,484$696,0000.00%
JANE STREET GROUP, LLC 7,557$256,0000.00%
View complete list of CALLIDITAS THERAPEUTICS AB shareholders